Convergys Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Convergys Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6954
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Convergys Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Convergys Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Convergys Corporation (Convergys or “the company”) is engaged in customer experience outsourcing. The company provides solutions across the customer lifecycle, including sales, customer service, technical support, customer retention and collections. It offers integrated agent, analytics and technology solutions and helps its clients to improve customer loyalty, reduce costs, and generate revenue through its expertise in customer care, analytics, tech support, collections, home agent, and end-to-end selling. The company offers services across industries, including communications and media, technology, financial services, retail, government and healthcare. It has facilities in North and South America, Europe, the Middle East, Africa and Asia-Pacific. Convergys is headquartered in Cincinnati, Ohio, the US.

Scope

- Detailed information on Convergys Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Convergys Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Convergys Corporation including a breakdown and examination of key business segments
- Intelligence on Convergys Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Convergys Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Convergys Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Convergys Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Convergys Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Convergys Corporation: Company Overview 9
Convergys Corporation: Overview and Key Facts 9
Convergys Corporation: Overview 9
Convergys Corporation: Key Facts 9
Convergys Corporation: Key Employees 11
Convergys Corporation: Key Employee Biographies 12
Convergys Corporation: Major Products and Services 16
Convergys Corporation: Company History 17
Convergys Corporation: Management Statement 24
Convergys Corporation: Locations and Subsidiaries 25
Convergys Corporation: Key Competitors 27
Convergys Corporation: Company Analysis 28
Convergys Corporation: Business Description 28
Convergys Corporation: SWOT Analysis 29
Convergys Corporation: SWOT Overview 29
Convergys Corporation: Strengths 29
Convergys Corporation: Weaknesses 30
Convergys Corporation: Opportunities 30
Convergys Corporation: Threats 31
Convergys Corporation: Corporate Financial Deals Activity 33
Convergys Corporation: Financial Deals Overview 33
Convergys Corporation: Targets and Partners 35
Convergys Corporation: Top Deals 2014 – 2018YTD* 36
Convergys Corporation: Advisors 37
Convergys Corporation: Top Legal Advisors 37
Convergys Corporation: Top Financial Advisors 37
Convergys Corporation: Mergers and Acquisitions 38
Convergys Corporation: Private Equity and Ownership 39
Convergys Corporation: Recent Developments 40
Convergys Corporation: News and Events Summary 40
Convergys Corporation: Business Expansion 43
Convergys Corporation: Business Reorganization 44
Convergys Corporation: Contracts 44
Convergys Corporation: Corporate Governance 45
Convergys Corporation: Financial Performance 45
Convergys Corporation: Red Flags/Distress Signals 45
Convergys Corporation: Strategy and Operations 46
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: Convergys Corporation: Key Facts
Table 2: Convergys Corporation: Key Employees
Table 3: Convergys Corporation: Company History
Table 4: Convergys Corporation: Locations and Subsidiaries
Table 5: Convergys Corporation: Key Competitors
Table 6: Convergys Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Convergys Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Convergys Corporation: M&A Average Deal Size - Value (US$m)
Table 9: Convergys Corporation: Targets and Partners
Table 10: Convergys Corporation: Top Deals 2014 - 2018YTD*
Table 11: Convergys Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: Convergys Corporation: Financial Advisor Ranking by Value (US$m)
Table 13: Convergys Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Convergys Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Convergys Corporation: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 16: Convergys Corporation: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 17: Convergys Corporation: News and Events Summary
Table 18: Convergys Corporation: Business Expansion
Table 19: Convergys Corporation: Business Reorganization
Table 20: Convergys Corporation: Contracts
Table 21: Convergys Corporation: Corporate Governance
Table 22: Convergys Corporation: Financial Performance
Table 23: Convergys Corporation: Red Flags/Distress Signals
Table 24: Convergys Corporation: Strategy and Operations

List of Figures
Figure 1: Convergys Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Convergys Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Convergys Corporation: M&A Average Deal Size - Value (US$m)
Figure 4: Convergys Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Convergys Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Convergys Corporation: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Convergys Corporation: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Convergys Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IMI plc:企業の戦略・SWOT・財務情報
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Sinopharm Group Co Ltd (1099):企業の財務・戦略的SWOT分析
    Sinopharm Group Co Ltd (1099) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Berg LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns o …
  • Arno Therapeutics Inc (ARNI)-医療機器分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Genetic Technologies Ltd (GTG)-医療機器分野:企業M&A・提携分析
    Summary Genetic Technologies Ltd (GTG) is a genetic tests company that offers testing products and services to assess sporadic breast cancer risk and cancer development, progression and management. It delivers the offerings by BREVAGen and BREVAGenplus tests. BREVAGen test enables the customers to a …
  • QAD Inc (QADA):企業の財務・戦略的SWOT分析
    QAD Inc (QADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • PT PLN (Persero):企業の発電所・SWOT分析2018
    PT PLN (Persero) - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Industrial and Commercial Bank of China Ltd:戦略・SWOT・企業財務分析
    Industrial and Commercial Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Industrial and Commercial Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • DePuy Synthes Inc:企業の製品パイプライン分析2018
    Summary DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic and neurological procedures. DePuy Synthes operates through eight divisions: joint reconstruction, sports medicine, neurological, spine, trauma, cranio-maxi …
  • RPC Group PLC:企業のM&A・事業提携・投資動向
    RPC Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RPC Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Dongfang Electric Corporation Ltd (1072)-エネルギー分野:企業M&A・提携分析
    Summary Dongfang Electric Corporation Ltd (DEC) a subsidiary of Dongfang Electric Corporation, is a power equipment and services company. It designs, manufactures, and sells power generation equipment, including turbines for hydro, thermal, and nuclear power generation, wind turbine generator sets, …
  • Defense Commissary Agency:企業の戦略的SWOT分析
    Defense Commissary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Natrix Separations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies, a subsidiary of Merck KGaA, is a supplier of single use and multi-cycle disposable chromatography products. The company offers NatriFlo HD-Q membrane adsorbers, an advanced material with a three-dimensional macroporous hyd …
  • Surgical Information Systems LLC-医療機器分野:企業M&A・提携分析
    Summary Surgical Information Systems LLC (SIS) is a healthcare information technology company that develops and provides software solutions. The company offers anesthesia information management system, business and clinical analytics software, patient tracking system, tissue tracking and management …
  • Dottikon ES Holding AG (DESN):製薬・医療:M&Aディール及び事業提携情報
    Summary Dottikon ES Holding AG (Dottikon) manufactures and commercializes active pharmaceutical ingredients (APIs), performance chemicals and intermediates for chemical and pharmaceutical industries. The company finds novel uses for hazardous reactions and continuous processing that facilitate the r …
  • Petroleos de Venezuela SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mitralign Inc-医療機器分野:企業M&A・提携分析
    Summary Mitralign Inc (Mitralign) is a medical device company that offers direct transcatheter annuloplasty system to treat both functional tricuspid regurgitation and mitral regurgitation. The company provides products such as crossing wire, pledget delivery catheter and placation lock delivery cat …
  • Audentes Therapeutics Inc (BOLD)-製薬・医療分野:企業M&A・提携分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆